GLOBAL COMPARATIVE ANTITHROMBIN-FIELD STUDY: IMPACT OF LABORATORY ASSAY VARIABILITY ON THE ASSESSMENT OF ANTITHROMBIN ACTIVITY MEASUREMENT
E Seth-Chhabraa, A Sadeghi-Khomamib, Mingjie-Liuc, Guy-Youngd, S W-Pipee, MC Ozelof, C Le-Camusa, M Tohg, SA Lima-Montalvaof, Marek-Demissiea
a Sanofi, Cambridge, United States
b Precision BioLogic, Dartmouth, Canada
c Sanofi, Bridgewater, United States
d Children's Hospital Los Angeles, Los Angeles, United States
e University of Michigan, Ann Arbor, United States
f Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
g Sanofi, France
Read
992
Timeswas read the article
254
Total PDF
738
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 28 | 7 | 35 |
| 2025 11 | 99 | 37 | 136 |
| 2025 10 | 81 | 28 | 109 |
| 2025 9 | 81 | 20 | 101 |
| 2025 8 | 53 | 23 | 76 |
| 2025 7 | 60 | 14 | 74 |
| 2025 6 | 52 | 25 | 77 |
| 2025 5 | 53 | 6 | 59 |
| 2025 4 | 50 | 9 | 59 |
| 2025 3 | 53 | 10 | 63 |
| 2025 2 | 37 | 11 | 48 |
| 2025 1 | 19 | 5 | 24 |
| 2024 12 | 21 | 13 | 34 |
| 2024 11 | 35 | 22 | 57 |
| 2024 10 | 16 | 24 | 40 |
Show all
